Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06690086 · ClinicalTrials.gov registry record

DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer

A clinical trial of Skin Cancer, sponsored by DermaSensor.

Completed
Registry status
1,028
Enrollment target
1
Study location

NCT06690086 is a study of Skin Cancer that has completed, run by DermaSensor. The registered enrollment target is 1,028 participants, above the 438-participant average among 40 other Skin Cancer trials with a reported enrollment target (135% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06690086, a study of Skin Cancer, has completed, sponsored by DermaSensor.

COMPLETED
Registry status
1,028 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the clinical validity of the proprietary DermaSensor Elastic Scattering Spectroscopy (ESS) device and classifier algorithm to support assessment of skin lesions suggestive of melanoma, basal cell carcinoma, and/or squamous cell carcinoma in the primary care setting.

Conditions Studied

Skin Cancer

Interventions

  • PROCEDURE Lesion biopsy
  • DEVICE DermaSensor Device Use

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 1,028 participants
Start Date 2020-08-17
Est. Completion 2021-12-09

Sponsor

DermaSensor

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06690086

The ClinicalTrials.gov registry entry for NCT06690086 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,028 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 438-participant average among 40 other Skin Cancer trials with a reported enrollment target (135% higher). The listed sponsor is DermaSensor, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin Cancer appearing as the primary indexed condition, and to 2 interventions - of which Lesion biopsy is the first listed.

NCT06690086 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06690086 about?

NCT06690086 is a clinical study titled "DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer". The purpose of this study is to evaluate the clinical validity of the proprietary DermaSensor Elastic Scattering Spectroscopy (ESS) device and classifier algorithm to support assessment of skin lesions suggestive of melanoma, basal cell carcinoma, and/or squamous cell carcinoma in the primary care s...

What is the current status of trial NCT06690086?

This trial is currently completed. The enrollment target is 1,028 participants. The study started on 2020-08-17. Estimated completion is 2021-12-09.

What conditions does trial NCT06690086 study?

This clinical trial studies the following conditions: Skin Cancer.

What interventions are being tested in trial NCT06690086?

The interventions under investigation include: Lesion biopsy (PROCEDURE), DermaSensor Device Use (DEVICE).

Who is sponsoring clinical trial NCT06690086?

This trial is sponsored by DermaSensor, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06690086 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Skin Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Skin Cancer

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.